{
    "clinical_study": {
        "@rank": "10039", 
        "acronym": "MTM", 
        "biospec_descr": {
            "textblock": "-  5 ml sample of whole blood will be collected during the study to assess the immunity\n           against various AAV serotypes\n\n        -  5 ml blood sample may be obtained for peripheral blood mononuclear cells (PBMC) to\n           quantify X-linked myotubular myopathy gene 1 (MTM1) production\n\n        -  24-hour urine collection will be performed every 6 months in order to measure urinary\n           creatinine excretion\n\n        -  Slides and tissue from a previously performed muscle biopsy will be obtained for a\n           central review and quantification of histo- and immunohistopathological features of MTM"
        }, 
        "biospec_retention": "Samples With DNA", 
        "brief_summary": {
            "textblock": "This is a prospective, non-interventional, longitudinal study of the natural history and\n      function of approximately 60 patients with MTM from the United States, Canada and Europe.\n      The duration of the study, including the enrollment period, will be 36 months.  Data from\n      the study will be used to characterize the disease course of MTM and determine which outcome\n      measures will be the best to assess the efficacy of potential therapies."
        }, 
        "brief_title": "Prospective, Longitudinal Study of the Natural History and Functional Status of Patients With Myotubular Myopathy (MTM)", 
        "completion_date": {
            "#text": "November 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Myotubular Myopathy", 
        "condition_browse": {
            "mesh_term": [
                "Muscular Diseases", 
                "Myopathies, Structural, Congenital"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion criteria:\n\n          -  Patients of any age (newborns included) may participate.\n\n          -  Patients over 18 years of age and parent(s)/legal guardian(s) of patients <18 years\n             of age must provide written informed consent prior to participating in the study and\n             informed assent will be obtained from minors at least 7 years of age when required by\n             regulation.\n\n          -  MTM resulting from a mutation in the MTM1 gene.\n\n          -  Male or symptomatic female. A symptomatic female will be defined by the motor\n             function assessment by Motor Function Measure (MFM) or North Star Ambulatory\n             Assessment (NSAA) below 80% of the total score.\n\n          -  Willing and able to comply with all protocol requirements and procedures.\n\n        Exclusion criteria:\n\n          -  Other disease which may significantly interfere with the assessment of MTM and is\n             clearly not related to the disease.\n\n          -  Currently enrolled in a treatment study; or treatment with an experimental therapy\n             other than pyridostigmine."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Investigative Research Centers"
            }
        }, 
        "enrollment": {
            "#text": "60", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 4, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02057705", 
            "org_study_id": "VAL-101-13"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "MTM", 
            "myotubular myopathy", 
            "X-linked centronuclear myopathy", 
            "inherited myopathies", 
            "neuromuscular diseases", 
            "hypotonia", 
            "genetic mutation"
        ], 
        "lastchanged_date": "April 24, 2014", 
        "link": [
            {
                "description": "National Institute of Health", 
                "url": "http://ghr.nlm.nih.gov/condition/x-linked-myotubular-myopathy"
            }, 
            {
                "description": "Muscular Dystrophy Association", 
                "url": "http://www.muscular-dystrophy.org/about_muscular_dystrophy/conditions/114_myotubular_centronuclear_myopathy"
            }, 
            {
                "description": "Orphanet", 
                "url": "http://www.orpha.net"
            }
        ], 
        "location": [
            {
                "contact": {
                    "email": "averion.gilberto@nih.gov", 
                    "last_name": "Mike Averion", 
                    "phone": "301-594-2760"
                }, 
                "facility": {
                    "address": {
                        "city": "Bethesda", 
                        "country": "United States", 
                        "state": "Maryland", 
                        "zip": "20892-3705"
                    }, 
                    "name": "National Institute of Health, Neuroscience Research Center Building 35, Room 2A-116 MSC 3705 35 Convent Drive"
                }, 
                "investigator": {
                    "last_name": "Carsten Bonnemann, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "heather.szelag@children's.harvard.edu", 
                    "last_name": "Heather Szelag", 
                    "phone": "617-355-6388"
                }, 
                "facility": {
                    "address": {
                        "city": "Boston", 
                        "country": "United States", 
                        "state": "Massachusetts", 
                        "zip": "02115"
                    }, 
                    "name": "Boston Children's Hospital, 300 Longwood Avenue"
                }, 
                "investigator": {
                    "last_name": "Basil Darras, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "kim.amburgey@sickkids.ca", 
                    "last_name": "Kim Amburgey", 
                    "phone": "(416) 813-7654", 
                    "phone_ext": "301707"
                }, 
                "facility": {
                    "address": {
                        "city": "Toronto", 
                        "country": "Canada", 
                        "state": "Ontario", 
                        "zip": "M5G 1X8"
                    }, 
                    "name": "Hospital for Sick Children, 555 University Avenue"
                }, 
                "investigator": {
                    "last_name": "James Dowling, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "m.annoussamy@institut-myologie.org", 
                    "last_name": "M\u00e9lanie Annoussamy", 
                    "phone": "+33 1 42 16 66 49"
                }, 
                "facility": {
                    "address": {
                        "city": "Paris Cedex 13", 
                        "country": "France", 
                        "zip": "75651"
                    }, 
                    "name": "Institut de Myologie, GH Piti\u00e9 Salp\u00eatri\u00e8re, B\u00e2timent Babinski"
                }, 
                "investigator": {
                    "last_name": "Laurent Servais, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": [
                "United States", 
                "Canada", 
                "France"
            ]
        }, 
        "number_of_groups": "1", 
        "official_title": "Prospective, Longitudinal Study of the Natural History and Functional Status of Patients With Myotubular Myopathy (MTM)", 
        "other_outcome": {
            "description": "A 5 ml sample of whole blood will be collected during the study to assess the immunity against various AAV serotypes.", 
            "measure": "Number of participants with an immune response against adeno-associated virus (AAV)", 
            "safety_issue": "No", 
            "time_frame": "Baseline Visit"
        }, 
        "overall_contact": {
            "email": "michelle.nelken@alopexx.com", 
            "last_name": "Michelle Nelken", 
            "phone": "617-755-4149"
        }, 
        "overall_official": {
            "affiliation": "Valerion Therapeutics, LLC", 
            "last_name": "Hal Landy, MD", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "United States: Institutional Review Board", 
                "Canada: Ethics Review Committee", 
                "France: Institutional Ethical Committee", 
                "France: Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament et des produits de sant\u00e9"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "November 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Study-specific functional assessments and patient questionnaires will be used and will be based on the age and ambulatory status of the participant", 
            "measure": "Time to characterize the disease course in MTM patients", 
            "safety_issue": "No", 
            "time_frame": "Up to 24 Months"
        }, 
        "reference": [
            {
                "PMID": "9931531", 
                "citation": "Herman GE, Finegold M, Zhao W, de Gouyon B, Metzenberg A. Medical complications in long-term survivors with X-linked myotubular myopathy. J Pediatr. 1999 Feb;134(2):206-14."
            }, 
            {
                "PMID": "12467733", 
                "citation": "Jungbluth H, Sewry CA, Buj-Bello A, Kristiansen M, \u00d8rstavik KH, Kelsey A, Manzur AY, Mercuri E, Wallgren-Pettersson C, Muntoni F. Early and severe presentation of X-linked myotubular myopathy in a girl with skewed X-inactivation. Neuromuscul Disord. 2003 Jan;13(1):55-9."
            }, 
            {
                "PMID": "12467749", 
                "citation": "McEntagart M, Parsons G, Buj-Bello A, Biancalana V, Fenton I, Little M, Krawczak M, Thomas N, Herman G, Clarke A, Wallgren-Pettersson C. Genotype-phenotype correlations in X-linked myotubular myopathy. Neuromuscul Disord. 2002 Dec;12(10):939-46."
            }, 
            {
                "PMID": "18817572", 
                "citation": "Jungbluth H, Wallgren-Pettersson C, Laporte J. Centronuclear (myotubular) myopathy. Orphanet J Rare Dis. 2008 Sep 25;3:26. doi: 10.1186/1750-1172-3-26. Review."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02057705"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "Study-specific functional assessments and patient questionnaires will be used and will be based on the age and ambulatory status of the participant", 
            "measure": "Change in disease severity and disease progression", 
            "safety_issue": "No", 
            "time_frame": "Baseline, Month 3 (EU only), Month 6, Month 12 and Month 24"
        }, 
        "source": "Valerion Therapeutics, LLC", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "Institut de Myologie, France", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Genethon", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "Valerion Therapeutics, LLC", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "February 2014", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "April 2014"
    }
}